Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

SHOCKING: 3 | Mind Blowing Facts

What's Going On With Tilray Brands Stock Today?

Tilray Brands Inc (NASDAQ:TLRY) stock is trending across social media Thursday, despite a lack of fresh company-specific news for the session. The cannabis and consumer brands company made several strategic moves in June that could be fueling the current interest.

Benzinga

How I'm Trading 2025's Biggest Winners And Losers

I just wrapped up a deep dive into what I'm calling the "real report card" for 2025 so far…and the results might surprise you.

Benzinga

Seeking Stability? These 3 Stocks Offer Strong Potential

Consumer staples companies may offer some protection against volatility during times of tariff uncertainty; these stocks could be a defensive play.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Are You Missing Out On This NASDAQ-Listed Weed Stock? Low-Cost Model Meets European Demand

Beyond Canada, this global cannabis company is focused on its international business, particularly in Germany, Australia, and the UK.

Benzinga

Decibel Cannabis: One Acquisition Could Be The Key To Unlocking $20M In Cash Flow

Decibel, a leading Canadian pre-roll franchise, may trade closer to larger market-cap cannabis stocks, according to analyst Pablo Zuanic.

Benzinga

Is Tilray Stock a Buy on Positive Cannabis Data?

Tilray reported a positive update for its chemo-related drug.

Barchart

1 Cannabis Stock I Would Buy, and One I Would Avoid

The cannabis industry is rapidly growing, but will Canadian players be able to keep up?

Barchart

Read news from The Economist, FT, and more,
with one subscription

Cresco vs. Tilray: Which Cannabis Stock Is a Better Buy?

Despite lingering regulatory challenges, the cannabis market is well-positioned for a steady expansion. Penny stock Cresco's solid financials and growth potential have won over analysts, while Tilray failed to impress with last quarter’s record revenue.

Barchart

2 Growth Stocks With 32% to 77% Upside in 2024

While AI stocks are the center of attention right now, many other growth stocks in various industries are going unnoticed. These stocks may benefit investors in the long run.

Barchart

Bullish or Bearish: 3 Pharma Options

The pharmaceutical industry’s robust outlook is driven by high healthcare spending globally, consistent R&D efforts, and the rapid adoption of advanced digital technologies. So, let’s analyze if investors should adopt a bullish or bearish stance on pharma stocks such as Tilray Brands (TLRY), CytomX Therapeutics (CTMX), and Wave Life Sciences…

StockNews.com

Key Cannabis Exec Changes Investors Should Know About: ScottsMiracle Gro, Tilray, Metrc, & Willow Industries

ScottsMiracle-Gro Nominates Edith Avilés To Board Of Directors

Benzinga

Jim Cramer Is Bullish On Cannabis Stocks Ahead Of Midterm Elections: 'I Say Buy Tilray'

Mad Money host Jim Cramer said last week during a Lightning Round segment that now is a good time to invest in Tilray.

Benzinga

What's Going On With Recreational Cannabis Sales In Canada? Analyst Examines The Situation

Sales growth in Canada appears to be stagnating for the cannabis sector.

Benzinga

Germany To Allow Adults To Possess An Ounce Of Cannabis And More In New Legalization Plan

A week after Germany's cannabis legalization measures were leaked, Health Minister Karl Lauterbach presented a plan to Chancellor Olaf Scholz's cabinet on Wednesday, reported Deutsche Welle.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Aurora & Tilray Better Positioned Than Other Cannabis Operators For Germany's Imminent Market Launch, Here's Why

A draft of the German government's cannabis legalization measure, which was leaked on Wednesday, indicates the EU country is getting close to legalizing retail distribution, possession a

Benzinga

Tilray Stock Soars Then Returns To Earth On Biden's Cannabis Pardon News, This Analyst Remains Neutral

On the heels of President Biden’s historic announcement that he was pardoning all federal marijuana possession convictions, Cantor Fitzgerald's

Benzinga

S&P 500 Gives Up Early Week Gains Following Latest Jobs Report: Is A Recession Looming?

After a strong two-day rally to start October, the SPDR S&P 500 ETF Trust (NYSE: SPY) gave up some of its gains on Friday following a mixed U.S. jobs report.

Benzinga

Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday's Mid-Day Session

Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Canopy Growth, Tilray Pull Back After Enjoying Surge Following Biden's Pardon: What's Up With These Cannabis Stocks?

Canopy Growth Corp. (NASDAQ: CGC) and Tilray Brands Inc. (NASDAQ: TLRY) were plunging over 13% and 11%, respectively, at one point Friday after skyrocketing on Thursday.

Benzinga

Levi Strauss, Tilray Brands And Some Other Big Stocks Moving Lower On Friday

U.S. stocks traded lower, with the Dow Jones dropping more than 400 points on Friday. Here are some big stocks recording losses in today’s session.

Benzinga

Tilray Net Loss Nearly Doubles From Year Ago, But Biden Marijuana Pardons Keep The Stock Up

Canadian marijuana giant Tilray Brands, Inc. (NASDAQ: TLRY) (TSX:TLRY) reported Friday financial results for the first fiscal quarter ended August 31, 2022, with net revenue of $153.2 million, which compares to revenue of $168.02 million for the same period last year.

Benzinga

Want Exposure To The Canadian Recreational Cannabis Market? These Are The 3 Best Picks, According To A Cantor Analyst

In a recent analyst note, Pablo Zuanic from Cantor Fitzgerald offered an update on the performance of Canada’s cannabis Licensed Producers in the August quarter, based on data obtained by the market scanner Hifyre.

Benzinga

Tilray To Guide Patients On Their Medical Cannabis Journey, Launches New Products & 'CannaPoints' Program

Tilray Brands, Inc.’s (Nasdaq: TLRY) (TSX:TLRY) Tilray Medical, has released new medical cannabis products, under Tilray and Aphria brands and launched CannaPoints, a new program designed to support pa

Benzinga

Is Tilray Still A Bear Play Or Is The Cannabis Giant Ready For A Big Break North?

Tilray Brands, Inc (NASDAQ: TLRY) was spiking up over 6% on Monday, attempting to break up from a falling channel on the daily chart, which the stock began trading in on Aug. 8.

Benzinga

Why Does This Undervalued Cannabis Stock Have An Encouraging Outlook?

The Analyst

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.